Source: International Congress 2016 – Clinical aspects of ILD
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Besma Dhahri-Ourari (Tunis, Tunisia), Besma Dhahri-Ourari, Lamia Missaoui, Jihen Bamar, Heifa Zaibi, Saloua Azzabi, Med Ali Baccar, Hichem Aouina. Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs). Eur Respir J 2016; 48: Suppl. 60, 815

Member's Comments

No comment yet.

Related content which might interest you: Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Source: Eur Respir J 2011; 38: 761-769 Year: 2011 The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014 The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease Source: Eur Respir Rev 2010 19: 237-241 Year: 2010 Bronchoalveolar lavage in children with diffuse lung disease Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease Year: 2008 Eosinophilic lung disease Source: International Congress 2016 – Orphan diseases I Year: 2016 Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia Source: International Congress 2014 – ILDs 2 Year: 2014 Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases? Source: International Congress 2015 – New insights into IIPs Year: 2015 Bronchoalveolar lavage Source: Eur Respir Mon; 2010: 48: 59–72 Year: 2010 Cytofluorimetric BAL cells characterization in IPF and in other ILD Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Bronchoalveolar lavage: how can we use it more effectively to define pathology? Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Cytokine profile in bronchoalveolar lavage fluid of fibrotic idiopathic intersticial pneumonias compared to fibrotic intersticial pneumonias in connective tissue diseases Source: International Congress 2016 – Connective tissue disorders Year: 2016 Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study Source: International Congress 2015 – IIPs: orphan Year: 2015 Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseases Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Characterization of inflammation in bronchoalveolar lavage of lung transplant patients Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Bronchoalveolar lavage in idiopathic pulmonary fibrosis Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Bronchoalveolar lavage in interstitial lung disease associated with collagen vascular disorders Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 What does bronchoalveolar lavage add to cryobiopsy in interstitial lung disease? Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 Clinical and immunological parameters in patients with newly diagnosed sarcoidosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013